Data is not available at this time.
3D Systems Corporation operates in the computer hardware sector, specializing in 3D printing and digital manufacturing solutions. The company serves a diverse range of industries, including medical, aerospace, automotive, and consumer goods, through its portfolio of 3D printers, materials, and software. Its offerings span stereolithography, selective laser sintering, and bioprinting technologies, supported by proprietary software like 3D Sprint and Geomagic for design optimization and workflow management. 3D Systems holds a competitive position in the additive manufacturing market, leveraging its extensive product ecosystem and direct sales channels. The company’s focus on precision healthcare and industrial applications differentiates it from generalist competitors, though it faces intense competition from both established players and emerging innovators. Its global footprint, with operations across the Americas, Europe, and Asia Pacific, provides access to key growth markets, but execution risks remain amid rapid technological advancements and shifting customer demands.
For FY 2024, 3D Systems reported revenue of €440.1 million, reflecting its broad industrial and healthcare customer base. However, the company posted a net loss of €255.6 million, with diluted EPS of -€1.94, indicating ongoing profitability challenges. Operating cash flow was negative at €44.9 million, exacerbated by capital expenditures of €16.1 million, underscoring inefficiencies in converting revenue to cash.
The company’s negative earnings and cash flow highlight struggles in achieving sustainable profitability. High R&D and operational costs, coupled with competitive pricing pressures, have eroded margins. Capital efficiency remains weak, as evidenced by the disparity between revenue growth and cash burn, though its €171.3 million cash reserve provides near-term liquidity.
3D Systems maintains a mixed balance sheet, with €171.3 million in cash and equivalents against €286.1 million in total debt. The net debt position raises concerns about leverage, though the absence of dividends allows for reinvestment. The company’s liquidity position is adequate for now, but sustained losses could strain financial flexibility.
Revenue trends suggest moderate demand, but profitability remains elusive. The company does not pay dividends, prioritizing growth initiatives and debt management. Long-term success hinges on scaling high-margin segments like healthcare and software, though execution risks persist.
With a market cap of €193 million and a beta of 1.95, 3D Systems is viewed as a high-risk, high-reward play in additive manufacturing. Investors appear skeptical of its turnaround potential, given persistent losses and competitive headwinds. Valuation multiples reflect subdued expectations until profitability improves.
3D Systems benefits from its diversified product suite and stronghold in niche markets like bioprinting. However, operational inefficiencies and macroeconomic uncertainties cloud its outlook. Strategic partnerships or M&A could bolster its position, but organic growth must accelerate to justify its risk profile.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |